Streetbeat News

ZDPY

Zoned Properties Inc

https://zonedproperties.com/

CEO

Bryan McLaren

Employees

4

Industry

Lessors of Nonresidential Buildings (except Miniwarehouses)

Open

0.46

Mkt cap

6.1M

Volume

1.8K

High

0.51

P/E Ratio

-50.50

52-wk high

0.70

Low

0.46

Div yield

N/A

52-wk low

0.35

Marijuana stocks experienced significant movement on a recent Monday, with Australis Capital, EVIO, and several others posting substantial gains, while a few companies like Rocky Mountain High and MJ Holdings faced declines. The article lists the percentage changes and closing prices for the gainers and losers in the sector.

Portfolio Pulse from Benzinga Insights

January 08, 2024 | 9:30 pm

The cannabis sector experienced significant movement on January 3, 2024, with a majority of stocks closing higher. Notable gainers included Affinor Growers, Khiron Life Sciences, and CLS Holdings USA, with increases of 74.05%, 66.67%, and 19.40% respectively. Eastside Distilling, Neptune Wellness Solutions, Cara Therapeutics, Genetic Technologies, Village Farms International, Green Thumb Industries, Mexco Energy, and Tilray Brands also saw gains. However, there were some losers, with 1933 Industries, Maple Leaf Green World, Global Compliance, Zoned Properties, and Psychemedics experiencing declines. Scotts Miracle Gro, Corbus Pharmaceuticals, Innovative Industrial Properties, MedMen Enterprises, ESCO Technologies, Item 9 Labs, and EnWave closed lower as well.

Portfolio Pulse from Benzinga Insights

January 03, 2024 | 9:30 pm

The article reports on significant price movements in marijuana stocks on January 1, 2024. Notable gainers include Cann Gr, Item 9 Labs, cbdMD, and others with increases ranging from 4.62% to 68.33%. Conversely, several companies experienced declines, with GrowLife leading the losers, dropping 66.67%. Other notable losers include Khiron Life Sciences, MJ Holdings, and OrganiGram Holdings, with decreases ranging from 3.10% to 25.00%. The article was produced by Benzinga's automated content engine.

Portfolio Pulse from Benzinga Insights

January 01, 2024 | 9:30 pm

On December 29, 2023, several cannabis stocks experienced significant movements. Notable gainers included Cann Gr, Item 9 Labs, and Maple Leaf Green World, with increases of 68.33%, 35.71%, and 24.21% respectively. Conversely, GrowLife, Khiron Life Sciences, and MJ Holdings were among the biggest losers, with declines of 66.67%, 25.00%, and 19.37%. OrganiGram Holdings, Village Farms Intl, and Tilray Brands, all NASDAQ-listed, also saw their shares drop by 7.80%, 4.76%, and 3.73%.

Portfolio Pulse from Benzinga Insights

December 29, 2023 | 9:30 pm

Cannabis stocks experienced significant movements on December 26, 2023. Notable gainers included GrowLife, 4Front Ventures, and C21 Investments, with increases of 40%, 22.53%, and 22.16% respectively. Canopy Growth, Eastside Distilling, Cresco Labs, and Tilray Brands also saw gains on NASDAQ. Conversely, Affinor Growers and Cann Gr were among the biggest losers, with shares dropping 58.79% and 57.02%. Urban-gro, Psychemedics, and Neptune Wellness Solutions were among NASDAQ-listed companies that saw their stock prices decline.

Portfolio Pulse from Benzinga Insights

December 26, 2023 | 9:30 pm

The marijuana stock market saw significant movement on December 22, 2023, with a number of stocks experiencing substantial gains, while a few faced notable losses. Neptune Wellness Solns (NEPT), Cara Therapeutics (CARA), Canopy Growth (CGC), Tilray Brands (TLRY), Corbus Pharmaceuticals (CRBP), Green Thumb Industries (GTBIF), Curaleaf Holdings (CURLF), Cresco Labs (CRLBF), Trulieve Cannabis (TCNNF), SNDL (SNDL), Cronos Group (CRON), GrowGeneration (GRWG), Aurora Cannabis (ACB), 22nd Century Group (XXII), and Village Farms Intl (VFF) were among the gainers. On the losing end, MPX International (MPXOF) saw a dramatic drop, while Psychemedics (PMD) and Urban-gro (UGRO) also closed down.

Portfolio Pulse from Benzinga Insights

December 22, 2023 | 9:30 pm

On December 21, 2023, several marijuana stocks experienced significant price movements. Notable gainers included Blueberries Medical, iAnthus Capital Holdings, and Heritage Cannabis Holding, with increases of 15.05%, 14.44%, and 12.73% respectively. Emeren Group, Corbus Pharmaceuticals, and Scotts Miracle Gro also saw their shares rise. Conversely, MJ Holdings, Khiron Life Sciences, and Item 9 Labs were among the biggest losers, with MJ Holdings dropping 30.41%. Other notable declines were observed in Eastside Distilling, Genetic Technologies, Canopy Growth, and Cresco Labs.

Portfolio Pulse from Benzinga Insights

December 21, 2023 | 9:30 pm

Cannabis stocks experienced significant movements on December 14, 2023. Genetic Technologies (GENE) saw a massive increase, closing up 474.82% at $3.15. Other gainers included Tilray Brands (TLRY), 22nd Century Group (XXII), Neptune Wellness Solns (NEPT), Mexco Energy (MXC), Emeren Group (SOL), and ESCO Technologies (ESE). Conversely, GrowGeneration (GRWG) and Greenlane Hldgs (GNLN) were among the losers, closing down 3.92% and 3.60% respectively.

Portfolio Pulse from Benzinga Insights

December 14, 2023 | 9:30 pm

The article lists the cannabis stocks that experienced significant gains and losses on December 4, 2023. Notable gainers include Global Compliance, Indiva, and Canopy Growth, with increases of 89.29%, 38.93%, and 22.59% respectively. On the losing side, Global Hemp Group led the declines with a 76.68% drop. The article reflects the volatility in the cannabis market and may influence investor sentiment.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 9:30 pm

Marijuana stocks experienced a bullish Friday with several companies posting significant gains. MGC Pharmaceuticals led the pack with a 41800.00% increase, while GrowLife saw the largest decline at 80.00%. The article lists the top gainers and losers in the sector, with notable gains from Canopy Growth, GrowGeneration, Cara Therapeutics, 22nd Century Group, Tilray Brands, and Scotts Miracle-Gro. Conversely, Neptune Wellness Solutions, Psychemedics, and Corbus Pharmaceuticals were among the notable losers.

Portfolio Pulse from Benzinga Insights

December 01, 2023 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.